ELK1 and neoplasm: Furthermore, when endogenous ELK-1 was silenced in the primary tumor culture of patient 624 (middle level of ELK-1 expression), CD133, NANOG, SOX2, and POU5F1 levels were all downregulated as compared to scramble RNA control (Figure 4E).